TRAX
First Tracks Biotherapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$36.28
+5.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | — | — | — | — |
| Cost of Revenue | 207.0K | 139.6M | 152.3M | — |
| Gross Profit | (207.0K) | (139.6M) | (152.3M) | — |
| Operating Expenses | ||||
| R&D Expense | 140.2M | 139.6M | 152.3M | 97.6M |
| SG&A Expense | 44.5M | 39.4M | 28.8M | 20.9M |
| General & Admin Expense | 35.3M | 39.4M | 28.8M | 20.9M |
| Selling & Marketing Expense | — | — | — | — |
| Other Expenses | — | (139.6M) | (152.3M) | — |
| Total Operating Expenses | 184.7M | 39.4M | 28.8M | 118.5M |
| Cost and Expenses | 184.9M | 179.0M | 181.1M | 118.5M |
| Operating Income (EBIT) | (184.9M) | (179.0M) | (181.1M) | (118.5M) |
| Non-Operating | ||||
| Interest Income | 11.4M | 12.9M | 17.4M | 12.3M |
| Interest Expense | — | — | — | — |
| Net Interest Income | 11.4M | 12.9M | 17.4M | 12.3M |
| Other Non-Op Income/Expense | 11.4M | 12.9M | 17.4M | 12.3M |
| Non-Operating Income (excl Interest) | — | — | — | — |
| EBT (Pre-Tax Income) | (173.5M) | (166.1M) | (163.7M) | (106.2M) |
| Income Tax Expense | — | — | — | — |
| Bottom Line | ||||
| Net Income | (173.5M) | (166.1M) | (163.7M) | (106.2M) |
| Earnings from Cont. Ops | (173.5M) | (166.1M) | (163.7M) | (106.2M) |
| Earnings from Discont. Ops | — | — | — | — |
| Bottom Line Net Income | (173.5M) | (166.1M) | (163.7M) | (106.2M) |
| Per Share | ||||
| Basic EPS | ($4.97) | $0.00 | $0.00 | ($3.05) |
| Diluted EPS | ($4.97) | $0.00 | $0.00 | ($3.05) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | ||||
| Basic Shares Outstanding | 35.4M | 34.7M | 34.7M | 34.7M |
| Diluted Shares Outstanding | 35.4M | 34.7M | 34.7M | 34.7M |
| Profitability Metrics | ||||
| EBITDA | (183.4M) | (176.6M) | (178.7M) | (116.1M) |
| D&A | 1.5M | 2.4M | 2.4M | 2.4M |
| EBIT | (184.9M) | (179.0M) | (181.1M) | (118.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026